Dynamic Advisor Solutions LLC trimmed its holdings in Waters Corporation (NYSE:WAT - Free Report) by 85.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,450 shares of the medical instruments supplier's stock after selling 8,431 shares during the period. Dynamic Advisor Solutions LLC's holdings in Waters were worth $544,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT grew its stake in Waters by 121.2% during the fourth quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 40 shares in the last quarter. SHP Wealth Management purchased a new stake in Waters during the fourth quarter valued at $32,000. DV Equities LLC bought a new stake in shares of Waters in the 4th quarter worth about $32,000. Anchor Investment Management LLC bought a new stake in shares of Waters in the 1st quarter valued at approximately $27,000. Finally, Resources Management Corp CT ADV purchased a new position in Waters during the first quarter worth $27,000. Institutional investors own 94.01% of the company's stock.
Insiders Place Their Bets
In other news, Director Christopher A. Kuebler sold 3,626 shares of the firm's stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the sale, the director directly owned 17,808 shares in the company, valued at $7,086,515.52. This trade represents a 16.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.31% of the company's stock.
Waters Stock Performance
Shares of NYSE WAT opened at $406.94 on Monday. The stock has a market cap of $39.96 billion, a price-to-earnings ratio of 101.48, a PEG ratio of 2.36 and a beta of 1.19. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The company has a 50 day simple moving average of $373.23 and a two-hundred day simple moving average of $345.27. The company has a current ratio of 0.77, a quick ratio of 0.50 and a debt-to-equity ratio of 0.32.
Waters (NYSE:WAT - Get Free Report) last posted its earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.01 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.62 billion. Waters had a net margin of 3.58% and a return on equity of 11.27%. The firm's quarterly revenue was up 113.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. As a group, analysts predict that Waters Corporation will post 14.57 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on WAT shares. HSBC raised their price target on Waters from $415.00 to $435.00 and gave the stock a "buy" rating in a research note on Wednesday, June 3rd. The Goldman Sachs Group boosted their price objective on shares of Waters from $380.00 to $425.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Wells Fargo & Company lifted their target price on Waters from $370.00 to $400.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 5th. Barclays increased their target price on shares of Waters from $425.00 to $460.00 and gave the company an "overweight" rating in a research report on Wednesday. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Waters in a research note on Friday, July 17th. Three research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $418.10.
Read Our Latest Report on Waters
About Waters
(
Free Report)
Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.
Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.
Read More
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.